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TheCRISPRs (ClusteredRegularly InterspacedShort
Palindromic Repeats) found in prokaryotic genomes
confer small RNA-mediated protection against
viruses and other invaders. CRISPR loci contain
iterations of a short repeat sequence alternating
with small segments of varying invader-derived
sequences. Distinct families of CRISPR-associated
Cas proteins function to cleave within the repeat
sequence of CRISPR transcripts and produce the
individual invader-targeting crRNAs. Here, we report
the crystal structure of Pyrococcus furiosus Cas6
bound with a repeat RNA at 3.2 A˚ resolution. In
contrast to other Cas families of endonucleases,
Cas6 clasps nucleotides 2–9 of the repeat RNA using
its two ferredoxin-like domains, and the enzyme-
anchored 50 end tethers the distal cleavage site of
the RNA between nucleotides 22 and 23 to the pre-
dicted enzyme active site on the opposite side of
the ferrodoxin-like domains. Our findings suggest
a wrap-aroundmechanism for CRISPRRNA recogni-
tion and cleavage by Cas6 and related processing
endonucleases.
INTRODUCTION
The CRISPR-Cas system confers adaptive and heritable immu-
nity against invading genetic elements in bacteria and archaea
(Bolotin et al., 2005; Horvath and Barrangou, 2010; Karginov
and Hannon, 2010; Marraffini and Sontheimer, 2010a; Mojica
et al., 2005; Sorek et al., 2008; van der Oost et al., 2009; Waters
and Storz, 2009). This recently identified microbial defense
system has been exploited in pathogen detection (Driscoll,
2009; Mokrousov et al., 2007), microbial ecology and evolution
studies (Andersson and Banfield, 2008; Heidelberg et al., 2009;
Snyder et al., 2010; Tyson and Banfield, 2008), andmaintenance
of domesticated bacteria (Barrangou et al., 2007; Mills et al.,
2009) and may have the potential to aid in combating the spread
of bacterial pathogens and antimicrobial resistance. CRISPR loci
are found in many archaeal and bacterial genomes, including
clinically important pathogens (Haft et al., 2005; Jansen et al.,
2002; Makarova et al., 2006). A CRISPR locus typically consists
of short (30–40 nucleotide) variable sequences interspersedStructure 19, 25between short (30–40 nucleotide) conserved repeat se-
quences, and is accompanied by one or more of the evolution-
arily linked sets of CRISPR-associated (cas) genes that encode
Cas proteins. The variable (alternatively ‘‘spacer’’) sequences
are derived from past invaders and provide the specificity for
recognition of and resistance against future infection (Barrangou
et al., 2007; Bolotin et al., 2005; Brouns et al., 2008; Marraffini
and Sontheimer, 2008; Mojica et al., 2005; Pourcel et al.,
2005). CRISPR locus transcripts are processed to small CRISPR
(cr)RNAs (also called prokaryotic silencing (psi)RNAs) that
contain individual invader-targeting sequences, and incorpo-
rated into effector complexes that silence invaders presumably
via interaction with DNA or RNA (Brouns et al., 2008; Carte
et al., 2008; Hale et al., 2009; Marraffini and Sontheimer, 2008).
Each of the sets ormodules of Cas proteins is thought to function
with the crRNAs and the core Cas proteins to affect acquisition of
invader-derived sequences and invader silencing. Indeed, an
effector complex comprised of the Cmr (Cas RAMP module)
proteins was recently shown to cleave RNA targets recognized
by the crRNAs (Hale et al., 2009). In some organisms it has
been found that silencing occurs at the DNA level, and though
the mechanism of silencing is not known in these cases,
evidence indicates that the CRISPR-Cas pathway discriminates
between self and nonself DNA based on the absence or pres-
ence of extended complementarity outside of the invader-target-
ing sequence of the crRNAs (Marraffini and Sontheimer, 2010b).
CRISPR RNA processing is essential to the function of the
defense pathway (Brouns et al., 2008). This essential function
is executed by distinct Cas proteins in organisms with different
modules of cas genes and CRISPR repeat sequences. In
Pyrococcus furiosus, CRISPR RNA is processed by the Cas6
protein, while in Escherichia coli and Pseudomonas aeruginosa,
processing is carried out by Cse3 (also called CasE) and Csy4,
respectively (Brouns et al., 2008; Carte et al., 2008; Haurwitz
et al., 2010). Cas6 is a ‘‘core’’ Cas protein that is commonly found
in organisms with four of the eight subtypes of cas genes defined
by Haft et al. (2005) (Tneap, Hmari, Apern, and Mtube), including
diverse archaea and bacteria. Cse3 and Csy4 are found in
bacteria with the Ecoli and Ypest subtype CRISPR systems,
respectively (Haft et al., 2005). The three known processing
endonucleases share little sequence homology. However, their
three-dimensional structures all exhibit the ferredoxin fold that
is also known to be RNA Recognition Motif (RRM) (Maris et al.,
2005), suggesting a related mechanism of RNA processing.
The RNA-bound Csy4 contains a single while both Cas6 and
Cse3 contain a tandem ferredoxin fold (Carte et al., 2008; Ebi-
hara et al., 2006; Haurwitz et al., 2010).7–264, February 9, 2011 ª2011 Elsevier Ltd All rights reserved 257
Figure 1. Overview of CRISPR RNA Processing Steps and Structural
Properties of Cas6
(A) crRNA biogenesis. The primary CRISPR transcript contains repeats (R, red
blocks) interspaced by guide sequences (G, gray blocks). The sequence of the
repeat (RNA used in this study) is shown. Cas6 cleaves within each repeat
(white dotted lines), releasing individual crRNA units (13 intermediates) that
are further trimmed at the 30 end by an unknown exonuclease(s).
(B) Overview of the Cas6-RNA complex structure shown in two orientations.
The protein is shown in teal and RNA is in red. The a helix a2 that contains
the putative catalytic residue, His46, is indicated. Nucleotides of the repeat
RNA are numbered from the 50 end.
See also Figures S1 and S2.
Structure
Structure of Cas6In the organisms where it has been investigated, mature
crRNAs have been found to retain 8 nucleotides of the repeat
sequence upstream of the invader targeting sequence (Brouns
et al., 2008; Hale et al., 2009; Haurwitz et al., 2010; Marraffini
and Sontheimer, 2008). Accordingly, the identified CRISPR
RNA endonucleases, Cas6, Cse3, and Csy4, each cleave 8
nucleotides upstream of the repeat/invader-targeting sequence
junction (Brouns et al., 2008; Carte et al., 2008; Haurwitz et al.,
2010). There is no significant similarity between the primary
sequences of the CRISPR repeat RNAs recognized and cleaved
by the three enzymes. The CRISPR repeat RNA that is cleaved
by P. aeruginosa Csy4 contains palindromic sequences that
are predicted to form a stable hairpin structure immediately
upstream of the cleavage site (Kunin et al., 2007), and the recent
cocrystal revealed that Csy4 interacts specifically with the
P. aeruginosa repeat RNA hairpin to place the cleavage site at
the base of the hairpin within the enzyme active site (Haurwitz
et al., 2010). The E. coli Cse3 substrate RNA is also predicted
to form an internal hairpin that terminates at the cleavage site
(Brouns et al., 2008). However, the P. furiosus repeat RNA recog-
nized and cleaved by Cas6 belongs to a different CRISPR repeat
class that is predicted to be nonstructured (Kunin et al., 2007).
Moreover, biochemical studies indicate that while sequences
near the cleavage site (e.g., A22 and A23; see Figure 1A) are
important for Cas6 cleavage, distal sequences near the 50
terminus of the CRISPR repeat (G1-A12; see Figure 1A) are
necessary and sufficient for Cas6 binding (Carte et al., 2008),
suggesting the necessity for a distinct RNA recognition and
cleavage site positioning mechanism.258 Structure 19, 257–264, February 9, 2011 ª2011 Elsevier Ltd All rIn order to better understand the mechanisms of CRISPR
RNA recognition and cleavage, we undertook further structural
and biochemical studies of Cas6. We determined the crystal
structures of P. furiosus (Pf) Cas6 bound to a Pf CRISPR
repeat RNA and two of its 50 fragments. In addition, we per-
formed extensive mutagenesis studies that support structural
observations. Both structural and biochemical data suggest
that Cas6, unlike previously described other CRISPR process-
ing endonucleases, binds unstructured precursor crRNA in
a wrap around model. Specific recognition of the 50 end of
the RNA by Cas6 tethers the cleavage end of the RNA to the
active site of Cas6.
RESULTS AND DISCUSSION
Overview
We obtained crystals of the previously characterized Pf Cas6
protein (Carte et al., 2008) bound with the full-length Pf CRISPR
repeat RNA (30 mer), the first 26 nucleotides of the repeat RNA
(26 mer), and the first 15 nucleotides of the repeat RNA
(15 mer) (Figure 1A), respectively. The 30 and 26 mer RNAs con-
tained 20-deoxymodifications at positions 22 and 23 designed to
prevent their cleavage by Cas6. Even though the three
complexes are crystallized in two different space groups, their
structures are indistinguishable within experimental error and
the structure of the highest resolution (3.2 A˚) (the 30 mer-bound
complex) is described here. We determined the structures by
a seleno-methionine single wavelength anomalous diffraction
method. Structure determination procedures are described in
detail in the Experimental Methods section. The Cas6-RNA
complex structure contains Pf Cas6 residues 1–8, 15–141, and
147–240 (wild-type length 264 amino acids) and nucleotides
2–10 of the 30 nucleotide Pf CRISPR repeat RNA. The rest of
the residues/nucleotides could not be modeled owing to struc-
tural disorder.
The bound RNA molecule was first located by electron densi-
ties computed using the experimental amplitudes and phases
of the protein coordinates prior to introduction of the RNA (see
Figure S1 available online). In addition, the positions of 2 nucleo-
tides,U2andU8,wereunambiguously determinedbyanomalous
difference Fourier methods using data collected from Cas6-RNA
complex crystals containing 5-bromouridine substitutions at
these two positions (Figure S2). Although two Cas6-RNA
complexes are in the asymmetric unit, they form a small interac-
tion interface (595 A˚2). Based on statistical observations on
crystal contacts, the small interface is suggestive of amonomeric
or a weak dimeric Cas6-RNA complex in solution (Janin et al.,
1988).
The overall structure of the Cas6-RNA complex reveals that
Cas6 interacts with single-stranded RNA. This structural
discovery is consistent with the lack of a stable structure of the
RNA both in the present and absence of Cas6 as observed by
melting curve analysis (Figure S3). Unlike the well-described
interactions between RRM and single stranded RNA, the RNA
does not interact with the characteristic b sheet of the RRM
domains of Cas6. Rather, the single-stranded RNA is bound at
the groove formed between the two RRM domains. Detailed
interactions between nucleotides of the RNA and Cas6 are
described below.ights reserved
Figure 2. Structural Comparison of Free and
RNA-Bound Cas6, the Surface Properties of the
Complex, and the Effect of G-Rich Loop Mutations
(A) Superimposed structures of Cas6 bound to RNA (teal)
and free Cas6 (gray). The putative catalytic residue (His46)
is indicated in magenta.
(B) Electrostatic potentials of Cas6 in the RNA-bound
complex are shown. The left view is the same as that
in A. Cas6 binds nucleotides 2–10 of the repeat RNA
(red) and is predicted to tether the 30 end of the repeat
RNA (dashed line) to its cleavage site (indicated by
His46). Note that the potential path overlaps with the
conserved Cas6-specific G-rich loop (G-loop).
(C) Impact on RNA cleavage (left) and binding (right) of
Cas6 by alanine substation of Gly223, Gly225, Gly231,
and Gly233 (G-loopm). The three concentrations of the
G-loopm protein used in the cleavage and binding experi-
ments were 0.5, 1, and 10 mM, respectively.
Structure
Structure of Cas6Molecular Basis of Interaction of Cas6with CRISPR RNA
In previous work, we determined that block substitution of the
first 8 nucleotides of the 30 nucleotide Pf CRISPR repeat
sequence disrupted binding of Cas6 and that an RNA comprised
of the first 12 nucleotides of the repeat was sufficient for Cas6
binding (Carte et al., 2008). In addition, we determined the struc-
ture of the Cas6 protein (Carte et al., 2008), however the molec-
ular basis for the interaction of Cas6 with CRISPR RNA was not
known.
In the cocrystal structure determined here, we find that nucle-
otides 2–10 of the single-stranded Pf CRISPR repeat RNA lie
along the positively charged central cleft formed by the two ferre-
doxin folds of Cas6 (Figure 2B). The overall binding surface is
wider at the two ends and narrows through themiddle of the cleft
(Figure 2B), suggesting a more important role played by nucleo-
tides bound in the middle than at the two ends of the surface in
RNA recognition. Pf CRISPR repeat nucleotides C5 and A6 are
bound in the narrowest part of the Cas6 cleft and are held tightly
in place by surrounding residues. These two nucleotides form an
impressive network of interactions with the protein via both base
and backbone functional groups (Figure 3A). The interactions
involve several well-conserved, positively charged amino acids
(Figures 3A and 4). Arg64, Lys188, and Lys190 interact with
the sugar phosphate backbone groups of C5 and A6. Arg64
also stacks on the nucleobase of C5 (Figures 3A and 4). Strik-
ingly, the nucleobases of C5 and A6 contact only protein back-
bone atoms (Figures 3A and 4), suggesting the importance of
shape recognition in this region.
The two ends of the RNA binding cleft make more moderate
contacts with the bound RNA, but nonetheless enhance RNA
recognition and interaction (Figure 2B). Nucleotides U2 and U3Structure 19, 257–264, February 9each make direct contacts with the protein (Fig-
ure 3A). The O2 atom of U3 is within 3.5 A˚ of
Phe80 and Glu62. A4 is flipped out and makes
a stacking interaction with the backbone of
resides 174–175 of a symmetry-related Cas6
and Glu238 (Figure 4). Nucleotides A7, A9, and
A10 also make several direct contacts with the
protein (Figure 4). Cas6 specifically recognizes
U8 within a deep protein pocket (Figure 3B).The Watson-Crick edge of the nucleobase of U8 lies against
the backbone of residues Lys190 and Arg191. In addition,
Tyr20, A7, U8, and, to some extent, A9 form a continuous base
stacking interaction that stabilizes the bound RNA in this region
(Figure 3B).
The contacts observed in the CRISPR RNA-Cas6 protein
complex indicate that Cas6 specifically interacts with nucleo-
tides U3, C5, A6, and U8 of the Pf CRISPR repeat. These 4 nucle-
otides are conserved in the seven CRISPR repeats found in
P. furiosus (Grissa et al., 2007). Consistent with key roles in
recognition and binding CRISPR RNAs deduced from interac-
tions observed in the costructure, we find that substitution of
C5, A6, and A7 (by G5, U6 and U7) abolishes RNA binding by
Cas6 in gel shift assays (Figures 5A and 5B, mutant H). Deletion
of G1-U3 or substitution of U2 and U3 (by A2 and A3) also abol-
ishes CRISPR RNA binding by Cas6 (Figures 5A and 5B,mutants
K and G). Disruption of recognition and binding by each of these
mutations also prevents Cas6 cleavage (Figure 5B). At the same
time, deletion of G1 or G1-U2 does not significantly impact
binding or cleavage activity (Figures 5A and 5B, mutants I and
J). The findings presented here delineate the mechanism of
CRISPR RNA recognition and binding by Cas6 and underscore
the importance of the interaction of Cas6 with the primary
binding site at the 50-end of the CRISPR repeat sequence.
CRISPR RNA Binding Tethers the RNA Cleavage Site
to the Putative Active Site of Cas6
Our biochemical and structural data indicate that recognition
and cleavage of CRISPR RNAs by Cas6 occur at physically
distant sites. The cocrystal structure described here reveals
that Cas6 specifically binds CRISPR RNA repeat nucleotides, 2011 ª2011 Elsevier Ltd All rights reserved 259
Figure 3. Key Interaction Features of the Cas6-RNA Complex
The protein is represented by surface (upper panels) or stick models (lower
panels) and the RNA is represented by red stick models. Contacts shorter
than 3.4 A˚ between RNA and protein atoms are indicated by dashed lines.
(A) Interactions between Cas6 residues and nucleotides 2–6.
(B) Interactions between Cas6 residues and nucleotides 7–10.
Structure
Structure of Cas62–10, 12 nucleotides upstreamof the cleavage site. Likewise, the
CRISPR RNA binding site of Cas6 identified here is on the oppo-
site face of the protein from the putative active site (Figure 1B,
bottom panel, and Figure 2B). Sequence analysis and compar-
ison with other riboendonucleases suggests that Tyr31, His46,
and Lys52 comprise the catalytic triad of Pf Cas6 (Carte et al.,
2008). Although their direct involvement in catalysis has not
been established, mutation of His46 and Tyr31 abolish detect-
able RNA cleavage activity without affecting RNA binding, and
mutation of Lys52 also significantly reduces RNA cleavage
activity but not binding (Carte et al., 2010). Likewise, in Cse3
and Csy4, mutation of a conserved histidine in a similar location
was deleterious to catalysis (Brouns et al., 2008; Haurwitz et al.,
2010). Furthermore, in Csy4, the relevant histidine forms close
contacts with the scissile phosphate of the RNA substrate, sup-
porting its role in catalysis (Haurwitz et al., 2010). Interestingly,
superimposition of the structures of the RNA-bound and free
Cas6 proteins shows that while the arrangement of most regions
of the protein is similar (0.94 A˚ rmsd for 221Ca atoms), a helix a2,
which holds the putative catalytic residue His46, is rotated 6
toward a helix a1 in the RNA-bound structure (Figure 2A) (Carte
et al., 2008) (PDBid: 3I4H). The observed shift indicates that RNA
binding induces a change in the predicted Cas6 catalytic region
located on the opposite face of the protein.
The insights provided by the Cas6-CRISPR RNA structure
suggest a path for the unobserved region of the repeat RNA,
connecting nucleotide 10, bound on the CRISPR RNA recogni-
tion face of Cas6, with nucleotides 22 and 23 in the putative
active site containing His46 (Figure 2B). The hypothetical path260 Structure 19, 257–264, February 9, 2011 ª2011 Elsevier Ltd All ris lined with positive electrostatic potential and passes over
the signature Cas6-specific G-rich loop (Figure 2B). Consis-
tently, mutation of Gly223, Gly225, Gly231, and Gly233 to
alanine completely abolished the RNA cleavage activity while
maintaining a weak RNA binding activity of Cas6 (Figure 2C).
The length of the intervening RNA is theoretically more than suffi-
cient to bridge the distance between the Cas6 RNA binding and
active sites. The fact that this region of the RNA is not observed in
the Cas6-RNA structures suggests that interactions of these
nucleotides with the protein are weak or transient.
In order to further investigate the role of the unobserved nucle-
otides that link the regions of the CRISPR repeat that interact
with the Cas6 binding and putative cleavage sites, we examined
the consequences of mutations in this region on binding and
cleavage by Cas6. In previous work, we had concluded that
substitutions, insertions and deletions of 4 nucleotides in the
region between the binding and cleavage sites disrupted
cleavage (Carte et al., 2008); however, the relevant mutations
analyzed in that work each disrupted nucleotides A9 and A10,
which we now know are constituents of the Cas6 binding site
(Figure 2B). The previous results confirm the importance of the
Cas6-A9 and A10 interactions identified here, but do not clearly
address the role of the intervening sequence. Therefore, we
generated RNAs with mutations in the region between nucleo-
tides 14–19 of the repeat. Deletion of 2–4 nucleotides from the
linker region did not prevent cleavage or binding (Figures 5A–
5C, mutants E, L, and O; data not shown). However, deletion
of either 5 or 6 nucleotides of the CRISPR repeat between the
Cas6 binding and cleavage sites prevented cleavage (Figures
5A and 5C, mutants M and N) but not binding (data not shown).
At the same time, insertion of 2 nucleotides in the linker region
did not significantly affect Cas6 binding or cleavage (Figures
5A and 5B, mutant F). These results are consistent with the
two site model for Cas6 recognition and cleavage of CRISPR
RNAs that has arisen from this work and suggest that a linker
of at least 8 nucleotides is required to bridge the Cas6 binding
and cleavage sites.
We further probed the regions of the CRISPR repeat RNA at
and downstream of the cleavage site, which are not observed
in the costructure. Consistent with previous results (Carte et al.,
2008), we found that removal of nucleotides 27–30 or 25–30,
downstream of the cleavage site (between nucleotides A22 and
A23), did not disrupt binding by Cas6 (Figures 5A and 5B, mutant
C and D). However, analysis of cleavage revealed that the repeat
RNA lacking nucleotides 25–30was not cleaved byCas6 (Figures
5Aand5B,mutantD), indicating that nucleotidesU25and/orG26
are important for cleavage. At the cleavage site, mutation of A23
to uridine shifted Cas6 cleavage upstream one position to after
nucleotide 21 as demonstrated by gel analysis and mass spec-
trometry (Figures 5A and 5D, mutant Q), and further 20-deoxy
modification of A22 did not alter the shifted cleavage site (Figures
5A and 5D, mutant P). Interestingly, however, 20-deoxymodifica-
tion of G21 in the context of the A23U mutation shifted the
cleavage site back to after position 22 (Figures 5A and 5D,
mutant R), suggesting a plasticity of the enzyme active site.
The recently characterized Csy4 CRISPR RNA endonuclease
is found in a set of bacteriawith similarCRISPR repeat sequences
that are predicted to form an internal hairpin (Kunin et al., 2007).
The cocrystal structure of Csy4 and an RNA substrate analogights reserved
Figure 4. Detailed Interactions between Repeat RNA Nucleotides and Cas6 Residues
RNA nucleotides are represented by red sticks and protein residues are by gray-blue-red sticks. Nucleotides 4 and 9 involve simple interactions and are thus not
included.
Structure
Structure of Cas6showed that a region of Csy4 adjacent to the active site specifi-
cally interactswith theRNAhairpin, positioning theRNAcleavage
site near the catalytic His (Haurwitz et al., 2010). The results pre-
sented here support a very different model for CRISPR RNA pro-
cessing by Cas6 (Figure 5E). Cas6 is tightly linkedwith 6 of the 12
CRISPR repeat sequence clusters identified by Kunin et al.
(2007). The repeat sequences found in bacteria and archaea
with Cas6 are predicted to be nonstructured or to have interme-
diate folding potential (Kunin et al., 2007). Our findings suggest
that this type of CRISPR repeat RNA wraps around the surface
of the processing endonuclease for recognition and cleavage.
Cas6binds 8 nucleotides near the 50 endof the repeat RNA tightly
and specifically on the ‘‘front’’ surface, which tethers the down-
stream cleavage site to the Cas6 active site on the ‘‘back’’
surface. Weak interactions may occur along the surface of
Cas6 between the RNA binding and cleavage sites. RNA binding
induces a change in the predictedCas6 active site that could play
a role in promoting cleavage. Processing of CRISPR transcripts
by Cas6 could occur simultaneously at multiple repeats as de-
picted, stochastically, or sequentially. The distinct tethered,
wrap-around mechanism of coupling CRISPR RNA recognition
and cleavage at distant sites in Cas6 highlights the remarkable
diversity in CRISPR machineries.
EXPERIMENTAL PROCEDURES
Protein Preparation
Pf Cas6 was cloned and expressed as previously described (Carte et al.,
2008). Selenomethionine (Se-Met) labeled PfCas6 was produced accordingStructure 19, 25to a procedure by Ramakrishnan and Biou (1997) and purified as described
(Carte et al., 2008). The G-loop mutant contains alanine substitutions at posi-
tions Gly223, Gly225, Gly231, and Gly233 and was purified by Ni-affinity chro-
matography and dialyzed to the same storage buffer as Cas6.
Crystallization
Pf repeat RNAs consisting of nucleotides 1–5, 1–26, and 1–30 (see Figure 1A)
were ordered from Integrated DNA Technology (Coralville, IA). The 26 and 30
mer RNAs contained 20-deoxy modification at positions 22 and 23 to prevent
cleavage during crystallization. Crystals of Pf Cas6-RNA complexes were ob-
tained by the vapor diffusion method in hanging drops. Pf Cas6 or the seleno-
methionine-labeled protein was combined with the repeat RNA or a fragment
in 1:1.2 molar ratio at a protein concentration of 30mg/ml and the protein-RNA
complex was mixed in a 1:1 volume ratio with a reservoir solution containing
20 mMMgCl2, 50 mM Na HEPES (pH 7.0), 1.4 M ammonium sulfate, 4% poly-
propylene glycol 400 (PEG400), 20 mM NiCl2, and 100 mM NaCl. Crystals
usually appeared in 2 days and grew to full size in a week, regardless of the
length of the RNA used. For diffraction studies, crystals were cryoprotected
with the same crystallization well solution supplemented with 10% ethylene
glycol prior to being plunged into liquid N2 and mounted to the goniometer
head. X-ray diffraction data were collected at the Southeast Regional Collab-
orative Access Team (SER-CAT) beamline 22ID or 22BM via remote access.
Despite crystal sizes of typically 400 3 400 mm 3 300 mm, all Pf Cas6-RNA
crystals diffracted anisotropically with the worst direction to 4 A˚ and the
best to 3.2 A˚. The data were processed with HKL2000 (Otwinowski and Minor,
1997). The crystals containing Pf Cas6 and any one of the three RNAs appear
sporadically in space group of either P3221 with unit cell dimensions a = b =
96.6 A˚, c = 165.5 A˚ or P3121 with unit cell dimensions a = b = 96.0 A˚, c =
82.8 A˚. The unit cell of the P3221 space group crystals is twice as large as
that of the P3121 crystals and thus contains two protein-RNA complexes in
each asymmetric unit. The two crystals containing 15 to 30 mer RNAs are
otherwise identical and have a Matthews coefficient of 2.75–3.13 A3/Da that
indicates a solvent content of 55.9%–60.6%. The crystal structure was7–264, February 9, 2011 ª2011 Elsevier Ltd All rights reserved 261
Figure 5. Analysis of Cas6 Binding and Cleavage of a Series of CRISPR Repeat RNA Mutants and a Proposed Model of Cas6 Function
(A) Sequences of thewild-type (A) andmutant repeat RNAs (B–R) used in Cas6 cleavage and binding studies.Mutant B (20-deoxymodification on positions 22 and
23) is used as a noncleavable substrate control as previously established by Carte et al. (2008). Substituted, inserted, or modified nucleotides are shown in red.
Deletions are indicated by spaces. ‘‘d’’ denotes 20-deoxy modification. Results are summarized on the right. For mutations near the cleavage site, the experi-
mentally observed cleavage position is denoted.
(B) Cleavage (upper panels) and binding (lower panels) of wild-type (A) and mutant RNAs (B-K) by Cas6.
(C) Cleavage and mass spectrometry analysis of the wild-type and mutant RNAs (L–O).
Structure
Structure of Cas6
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Table 1. Data Collection and Refinement Statistics
Data Collection Statistics
Space group P3221
a 96.6
b 96.6
c 165.5
Resolution range (A˚) 100.0–3.2 (3.3–3.2)
No. of observed unique
reflections
14,419 (557)
Redundancy 25.68 (12.3)
Completeness (%) 92.1 (68.8)
I/s(I) 37 (2.1)
Rsym(%) 9.9 (40.1)
Refinement statistics
Resolution range (A˚) 100.0–3.2 (3.3–3.2)
Rwork (%) 26.6
Rfree (%) 31.7
Model information
No. of protein-RNA
complexes
2
No. of protein/RNA atoms 3822/401
No. of amino-acid/
nucleotide
488/19
Root-mean-square deviations (rmsd)
Bond length(A˚) 0.011
Bond angle() 1.680
Protein/RNA 159.1/200.6
Ramachandran plot of protein residues
Most favored region (%) 74.0
Additionally allowed region
(%)
21.6
Generously allowed region
(%)
4.2
Disallowed region (%) 0.2
Values in parentheses are those for the last resolution shell.
Structure
Structure of Cas6determined from a crystal in P3221 space group containing the full-length (30
mer) RNA.
Structure Determination
The structure of the 30 mer-bound Pf Cas6 complex in P3221 space group was
determinedbyaSAD (singlewavelengthanomalousdiffraction)method.TheSe-
SAD data produced sufficient quality for the placement and modeling the Cas6
protein. However, anisotropy of the data introduced noise in density that pre-
vented unambiguous identification of RNA nucleotides and ultimately high
B-factors of the refined structure (Table 1). Toensure the placement of thenucle-
otides, we obtained crystals and diffraction data for the endonuclease bound
with the repeat RNA with site-specific substitutions of 5-bromouridine at posi-
tions 2 and 8. The two bromide positions were unambiguously identified using
difference anomalous peaks computed from the diffraction data (Figure S2).(D) Cleavage of repeat RNAs containing mutation A23U. Sizes of cleavage produc
mass spectrometric methods (Bruker, autoflex III) is shown in the right panel. The
that from cleavage of the A23Umutant RNA. The predictedmolecular weights of th
(E) Depiction of a beads-on-a-string model of CRISPR RNA processing by Cas6
shown in gray. Individual Cas6 proteins bind the 50 regions of the CRISPR repe
(scissors).
See also Figure S3.
Structure 19, 25Iterative model building and structure refinement were done with the PHENIX
program suite (Adams et al., 2002), COOT (Emsley and Cowtan, 2004), and O
(Jones et al., 1991) before RNA nucleotides were introduced. The final model
was validated by PROCHECK (Laskowski et al., 1993). The refinement statistics
are shown in Table 1. The structures in the P3121 space group could be readily
obtained by molecular replacement using a Cas6 structure as the search probe
and no differences from that determined from the P3221 were found other than
the switch of noncrystallographic to crystallographic symmetry.
RNA-Binding and Cleavage Reactions
RNA cleavage reactions were initiated by addition of 1 mM enzyme to a 20 ml
solution containing 0.05 pmol of 50 end 32P-radiolabeled RNA, 0.02 M HEPES-
KOH (pH 7.0), 0.25 M KCl, 0.075 M DTT, 0.0015 M MgCl2, 5 mg E. coli tRNA,
and 10%glycerol at 70C.Half of the reactionwas loaded directly onto a nonde-
naturing 10% polyacrylamide gel to assess RNA binding and the other half was
loaded onto a denaturing 15% polyacrylamide gel in 7M urea to assess RNA
cleavage. Radiolabeled RNAs were visualized by phosphorimaging.
Mass Spectrometry
MALDI-TOFmass spectrometrywas used to confirm the cleavage products for
the wild-type (WT) and mutant (A23U) RNAs. The RNA cleavage reaction was
carried out as described above and was followed by phenol extraction and
ethanol precipitation to isolate the RNA components. The sample was resus-
pended in 10 ml water and purified using aC18 ZipTip (ZipTip Pipette Tips,Milli-
pore) before being spotted on a matrix. The matrix solution contains 70 mg/ml
3-hydroxypicolinic acid and picolinic acid (9:1) and 50% ACN. The negative
ions/reflector mode of the Autoflex III mass spectrometer (Bruker Daltonics)
was utilized.
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